Media

EDWARDSVILLE, IL (FEBRUARY 24, 2025) – Flint Cooper Cohn Thompson & Miracle proudly announces the addition of Karoline Carstens as the firm’s newest partner, reinforcing its nationally recognized asbestos litigation practice with her nearly two decades of trial preparation experience and award-winning legal advocacy. Carstens has dedicated her career to securing justice for individuals and families affected by asbestos-related diseases, recovering hundreds of millions of dollars for her clients.  “Karoline’s unparalleled commitment to her clients, her extensive litigation experience and her strategic approach to asbestos cases make her an invaluable addition to Flint Cooper,” said Tim Thompson, partner. “Her history of achieving significant settlements, coupled with her passion for advocacy, strengthens our ability to deliver results for those harmed by corporate negligence.”  Carstens previously spent 17 years at a national asbestos firm, where she played a pivotal role in high-stakes asbestos litigation across the country. She managed complex trial strategies, discovery, motion practice, depositions and appeals, and was deeply involved in every step of her clients’ cases. Her remarkable legal skills and dedication to justice earned her the prestigious Illinois State Bar Association’s (ISBA) Young Lawyer of the Year Award in 2016, recognizing her exceptional litigation results and commitment to

EDWARDSVILLE, IL (AUGUST 14, 2024) – Flint Cooper is proud to announce that Alex Parker has been appointed to the Leadership Development Committee (LDC) in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, MDL No. 3092. This appointment by the United States District Court for the Northern District of Ohio, Eastern Division, underscores Parker’s commitment to the practice of mass tort litigation and his potential as a future leader in this area. “Alex Parker’s appointment to the Leadership Development Committee is a testament to his dedication,” stated Ethan Flint, co-managing member of Flint Cooper. “This appointment will provide him with invaluable experience, further enhancing our firm’s ability to advocate for our clients.” The LDC was established to mentor up-and-coming attorneys and foster their professional growth with real substantive work and constructive supervision. Through this initiative, the Court aims to cultivate the next generation of MDL leaders by allowing less experienced attorneys to collaborate closely with seasoned members of the Plaintiffs’ Leadership Committee. As a member of the LDC, Parker will be working directly under the guidance of the Executive Committee co-leads. The role requires a deep understanding of the litigation, a commitment to excellence and the ability to work effectively with

Flint Cooper, a leading advocate for victims of asbestos exposure, is proud to announce its rebranding to “Flint Cooper Cohn Thompson & Miracle,” reflecting the firm’s continued growth and the addition of three partners: Randy Cohn, Tim Thompson and Trent Miracle. As Flint Cooper expands its legal team to better serve clients nationwide, the addition of Randy Cohn, Tim Thompson and Trent Miracle further strengthens the firm’s commitment to providing exceptional legal representation in asbestos and pharmaceutical-related litigation. With extensive experience and a proven track record of success, these partners bring a wealth of knowledge and expertise to the firm. “We are thrilled to welcome Randy, Tim and Trent to our partnership because their addition sends a strong signal to the industry of our continued mission of fighting for justice on behalf of individuals and families injured by bad-acting corporations,” stated Ethan Flint, co-managing member of Flint Cooper. “Their dedication to advocacy and their exceptional legal acumen make them invaluable additions to our team.” “Joining the ranks of partners is a testament to the dedication and hard work we have put into serving our clients,” remarked Randy Cohn. “I am grateful for the trust and confidence Ethan and Jeff have

Edwardsville, Illinois (APRIL 24, 2024) – Flint Cooper proudly announces the addition of 13 exceptional professionals to its legal team. Leading the firm’s expansion is Randy Cohn and Tim Thompson, veteran and experienced litigators renowned for their expertise in mesothelioma and lung cancer litigation, as well as a team of accomplished attorneys, and a dedicated cadre of support staff. Flint Cooper’s commitment to providing unparalleled legal representation for individuals and families affected by asbestos-related diseases is underscored by the addition of these distinguished professionals. With decades of combined experience in navigating the complexities of asbestos litigation, the newly appointed partners bring a wealth of knowledge and a proven track record of securing over $2 billion for thousands of clients. “Our firm is honored to welcome such an esteemed group of legal professionals,” stated Ethan Flint, co-managing member of Flint Cooper. “Randy, Tim and their teams’ expertise and dedication to advocating for victims of asbestos exposure align perfectly with our firm’s mission to deliver exceptional legal representation and compassionate support to those facing the devastating impact of mesothelioma and lung cancer.” Joining Cohn and Thompson at the partnership ranks are Todd Gampp, Michael Hickey, Ryan Kiwala, Kerry O’Sullivan, John Richardson and Rob

Edwardsville, Illinois (MARCH 08, 2024) – Flint Cooper proudly announces that one of its esteemed attorneys, Trent Miracle, has been appointed to serve as Co-Lead Counsel in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, MDL No. 3092. This prestigious appointment by the United States District Court for the Northern District of Ohio, Eastern Division, recognizes Miracle’s exceptional legal acumen and dedication to justice. In this role, Miracle will be responsible for coordinating plaintiffs’ activities during pretrial proceedings, ensuring that the rights of those affected by the Suboxone products are protected, and advocating for their interests throughout the litigation process. “We are incredibly proud of Trent’s appointment to this important leadership position,” said Flint Cooper Managing Partner, Ethan Flint. “His commitment to excellence and tireless advocacy make him an invaluable asset to our firm and to the clients we serve.” Additionally, Flint Cooper extends heartfelt congratulations to the other attorneys appointed to key leadership positions in this litigation: Each of these individuals brings a wealth of experience and expertise to their respective roles, and we commend them for their dedication to advancing justice on behalf of the plaintiffs. For media inquiries or further information, please contact Fred Licon at (618) 277-4888 or via

EDWARDSVILLE, IL (SEPTEMBER 19, 2023) – Flint Cooper is pleased to announce that Trent Miracle has joined the firm. Miracle will serve as the managing member of the firm’s mass torts practice. With over 25 years of experience handling a broad array of mass tort cases, Miracle has helped thousands of people harmed by the negligence of pharmaceutical giants Johnson & Johnson, AbbVie, Bayer and Merck. At Flint Cooper, Miracle and his experienced team of professionals will litigate the firm’s mass tort cases, as well as manage the strategic direction of the practice. “We are thrilled to welcome a seasoned veteran like Trent to our team. He is an experienced litigator in high-profile casesand will be taking our mass torts practice to the next level,” said Ethan Flint, co-managing member of Flint Cooper. Over his career, Miracle and his team have secured over $2 billion in settlements for clients injured by dangerous drugs and defective medical devices, including notable pharmaceutical settlements involving Bextra, Ephedra, Ortho Evra and Vioxx. Miracle’s leadership, expertise and professionalism have led federal judges to appoint him to serve on plaintiffs’ steering committees for several multidistrict litigations (MDLs) involving Yaz, DePuy hip replacements and Propecia. Most notably,